Top

Published in:

01-12-2011 | Pancreatic Tumors

Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection

Authors: Stefano Partelli, MD, Stefano Crippa, MD, Giuliano Barugola, MD, Domenico Tamburrino, MD, Paola Capelli, MD, Mirko D’Onofrio, MD, Paolo Pederzoli, MD, Massimo Falconi, MD

Published in: Annals of Surgical Oncology | Issue 13/2011

Abstract

Background

The value of splenic vessels invasion (which identified T3 tumors) in prognosis after resection for pancreatic ductal adenocarcinoma (PDA) of the body and tail has not been extensively investigated. The goal of this study was to evaluate prognostic factors in PDA of the body/tail, emphasizing the role of splenic vessels infiltration.

Methods

Between 1990 and 2008, 87 patients who underwent distal pancreatectomy (DP) for histologically proven PDA of the body and tail were analyzed. Clinicopathological prognostic factors for survival were evaluated. Univariate and multivariable analyses were performed.

Results

Postoperative morbidity was 31% with no mortality. The 1-, 3-, and 5-year overall survival rates were 77%, 48%, and 24.5%, respectively. Invasion of the splenic artery (SA) was observed in 19 patients (22%). Patients with SA invasion had a significantly poorer prognosis compared with those without SA invasion (median survival: 15 vs. 39 months, P = 0.014). On multivariable analysis, adjuvant therapy, poor differentiation (G3/G4), R2 resection, the presence of lymph node metastases, and SA invasion were independent predictors of survival.

Conclusions

Along with other well-known prognostic factors, invasion of SA is an independent predictor of poor survival in PDA of the body/tail. In case of the presence of SA infiltration, neoadjuvant treatment should be considered. SA infiltration might be reclassified from a T3 to T4 tumor.

Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;223:506–11.PubMedCrossRef

Nordback IH, Hruban RH, Boitnott JK, et al. Carcinoma of the body and tail of the pancreas. Am J Surg. 1992;164:26–31.PubMedCrossRef

Johnson CD, Schwall G, Flechtenmacher J, et al. Resection for adenocarcinoma of the body and tail of the pancreas. Br J Surg. 1993;80(9):1177–9.PubMedCrossRef

Nakao A, Harada A, Nonami T, et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg. 1997;84(8):1090–2.PubMedCrossRef

Schwarz RE, Harrison LE, Conlon KC, et al. The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J Am Coll Surg. 1999;188(5):516–21.PubMedCrossRef

Sperti C, Pasquali C, Pedrazzoli S, et al. Ductal adenocarcinoma of the body and tail of the pancreas. J Am Coll Surg. 1997;185(3):255–9.PubMed

Shoup M, Conlon KC, Klimstra D, et al. Is extended resection for adenocarcinoma of the body of the pancreas justified? J Gastrointest Surg. 2003;7(8):946–52.PubMedCrossRef

Strasberg SM, Linehan DC, Hawkins WG, et al. Radical anterograde modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg. 2007;204(2):244–9.PubMedCrossRef

Christein JD, Kendrick ML, Corey WI, et al. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J Gastrointest Surg. 2005;9(7):922–7.PubMedCrossRef

10.

Fujita T, Nakagohri T, Gotohda N, et al. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas. 2010;39(1):e48–54.PubMedCrossRef

11.

Wu X, Tao R, Lei R, et al. Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience. Ann Surg Oncol. 2010;17(5):1359–66.PubMedCrossRef

12.

Konishi M, Kinoshita T, Nakagori T, et al. Distal pancreatectomy with resection of the celiac axis and reconstruction of the hepatic artery for carcinoma of the body and tail of the pancreas. Hepatobiliary Pancreat Surg. 2000;7(2):183–7.CrossRef

13.

Yekebas EF, Bogoevski D, Cataldegirmen G, et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg. 2008;247(2):300–9.PubMedCrossRef

14.

Hirano S, Kondo S, Hara T, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg. 2007;246(1):46–51.PubMedCrossRef

15.

Sobin LH, Gospodarowicz MK, Wittekind C. UICC: TNM classification of malignant tumors, 7th edn. Oxford: Wiley-Blackwell; 2009.

16.

Kanda M, Fujii T, Sahin TT, et al. Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas. Ann Surg. 2010;251(3):483–7.PubMedCrossRef

17.

Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. Am J Roentgenol. 1997;168(6):1439–43.

18.

Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M; International Study Group on Pancreatic Fistola Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.PubMedCrossRef

19.

Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200–10.PubMedCrossRef

20.

Kennedy EP, Yeo CJ. The case for routine use of adjuvant therapy in pancreatic cancer. J Surg Oncol. 2007;95:597–603.PubMedCrossRef

21.

Picozzi VJ, Pisters PWT, et al. Strength of the evidence: adjuvant therapy for resected pancreatic cancer. J Gastrointest Surg. 2008;12:657–61.PubMedCrossRef

22.

Barugola G, Partelli S, Marcucci S, et al. Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol. 2009;16(12):3316–22.PubMedCrossRef

23.

Nakao A, Harada A, Nonami T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas. 1996;12:357–61.PubMedCrossRef

24.

Japan Pancreatic Society. Classification of pancreatic carcinoma, 6th edn. Tokyo: Kanehara; 2009.

25.

Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and the role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–46.PubMedCrossRef

26.

Springett GM, Hoffe SE. Borderline resectable pancreatic cancer: on the edge of survival. Cancer Control. 2008;15(4):295–307.PubMed

Title: Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection
Authors: Stefano Partelli, MD
Stefano Crippa, MD
Giuliano Barugola, MD
Domenico Tamburrino, MD
Paola Capelli, MD
Mirko D’Onofrio, MD
Paolo Pederzoli, MD
Massimo Falconi, MD
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 13/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-011-1769-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 13/2011

Office Ductoscopy for Surgical Selection in Women with Pathologic Nipple Discharge

Robot-Assisted Spleen-Preserving Laparoscopic Distal Pancreatectomy

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin

Sarcoma Lung Metastases Treated with Percutaneous Radiofrequency Ablation: Results from 29 Patients

Oncologic Impact of the Curettage of Grade 2 Central Chondrosarcoma of the Extremity